Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Namespace $42M Series BVolantis $88M Series ARanked by rounds participated in, from announcements in Sep 25, 2026 – Oct 24, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Namespace $42M Series BVolantis $88M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Hestus, Inc. $7.4M SeedDaedal Systems $4M FundingNew companies 2 · Follow-on 0
Stages: Undisclosed 2
LAUNCHub Fund III €65M Fund first closeHeadline EU VIII $400M Venture capital fund final closeNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Homeward $120M Series DNscale $3.4B Pre-IPO convertible loan notesNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Headline EU VIII $400M Venture capital fund final closeEverphone €15M €15 million corporate loan refinancingNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Homeward $120M Series DRiskScout Undisclosed UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
FRANK Undisclosed UndisclosedHumanos $3.2M SeedNew companies 1 · Follow-on 1
Stages: Series A 1, Undisclosed 1
Volantis $88M Series AEfficient Computer $100M Additional fundingNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Varda $251M Series DNscale $3.4B Pre-IPO convertible loan notesNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Miter $40M Series BInstinct $1B Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
AnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Kuro Technology €10M SeedReverion $175M Series BNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
CScale $145M Series CGeneral Intuition $220M UndisclosedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
BridgeSmile Co., Ltd. ¥819M Series ASmolt Co., Ltd. ~¥200M Pre-Series A extension“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.